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Abstract
Pregnancy is a complicated and long procedure during one or more offspring development
inside a woman. A short period of oxygen shortage after birth is quite normal for most babies
and does not threaten their health. However, if babies have to suffer from a long period of
oxygen shortage, then this condition is an indication of pathological fetal intolerance, which
probably causes their death. The identification of the pathological fetal intolerance from the
physical oxygen shortage is one of the important clinical problems in obstetrics for a long
time. The clinical syndromes typically manifest five symptoms that indicate that the baby
may suffer from fetal intolerance. At present, liquid biopsy combined with high-throughput
sequencing or mass spectrum techniques provides a quick approach to detect real-time
alteration in the peripheral blood at multiple levels with the rapid development of molecule
sequencing technologies. Gene methylation is functionally correlated with gene expression;
thus, the combination of gene methylation and expression information would help in screen-
ing out the key regulators for the pathogenesis of fetal intolerance. We combined gene
methylation and expression features together and screened out the optimal features, includ-
ing gene expression or methylation signatures, for fetal intolerance prediction for the first
time. In addition, we applied various computational methods to construct a comprehensive
computational pipeline to identify the potential biomarkers for fetal intolerance dependent on
the liquid biopsy samples. We set up qualitative and quantitative computational models for
the prediction for fetal intolerance during pregnancy. Moreover, we provided a new prospec-
tive for the detailed pathological mechanism of fetal intolerance. This work can provide a
solid foundation for further experimental research and contribute to the application of liquid
biopsy in antenatal care.
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Introduction
Pregnancy is a complicated and long procedure during one or more offspring development
inside a woman [1, 2]. Various pathological syndromes and severe situations may occur during
pregnancy [3–5]. Fetal intolerance, which is also known as fetal distress, is one of the common
but dangerous situations during birth processes [6]. It generally refers to babies suffering from
oxygen shortage during the birth processes [6–8]. A short period of oxygen shortage after birth
is quite normal for most babies and does not threaten their health [7]. However, if babies have
to suffer from a long period of oxygen shortage, then this condition is an indication of patho-
logical fetal intolerance, which probably causes their death.
The identification of the pathological fetal intolerance from the physical oxygen shortage is
one of the important clinical problems in obstetrics for a long time. The following five symp-
toms according to the clinical syndromes indicate that the baby may suffer from fetal intoler-
ance [9–11]:1) high heart rate or tachycardia; 2) low heart rate or bradycardia; 3) irregular
heart rates or arrhythmia; 4) lack of movement in the womb; and 5) stool found in the amni-
otic fluid. For example, the alteration of the heart rate is quite normal for new born babies.
However, the constant abnormal heart rate patterns and alterations strongly indicate patholog-
ical fetal intolerance [11]. Fetal intolerance is actually a quite severe disease and leads to the
death of babies. The medical staff must save the baby after the manifestation of severe symp-
toms and try to find out an accurate and effective way to predict fetal intolerance (e.g., quick
early diagnosis).
With the rapid development of molecule sequencing technologies, liquid biopsy [12–14]
combined with high-throughput sequencing or mass spectrum techniques, provides a quick
approach to detect real-time alteration in the peripheral blood at multiple levels (e.g., genomics
[12], transcriptomics [13], and proteomics [14]). Various genetic variations, such as mutations
in IGF-II and H19, have already been confirmed to participate in the pathogenesis of fetal
intolerance [15]. The genomic methylation status has also been confirmed to be functionally
correlated with fetal intolerance. In 2018, an independent study on the methylation status of
SLC9B1 has confirmed that such methylation pattern can actually predict the clinical outcome
of potential pregnancy related to fetal intolerance [16]. Gene methylation is functionally corre-
lated with gene expression. Thus, the combination of gene methylation and expression infor-
mation would help in screening out the key regulators for the pathogenesis of fetal intolerance.
We combined gene methylation and expression features together and screened out the opti-
mal features, including gene expression or methylation signatures for fetal intolerance predic-
tion, for the first time. Moreover, we have applied various computational methods to construct
a comprehensive computational pipeline to identify the potential biomarkers for fetal intoler-
ance dependent on the liquid biopsy samples. We set up qualitative and quantitative computa-
tional models for the prediction for fetal intolerance during pregnancy. Furthermore, we
provided a new prospective for the detailed pathological mechanism of fetal intolerance. This
work can provide a solid foundation for further experimental research and contribute to the
application of liquid biopsy in the antenatal care.
Method
Data
We downloaded the gene expression and methylation profiles of fetal intolerance from Gene
Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE107460) [16]. We extracted 22 fetal intolerance and 96 control samples with gene expres-
sion and methylation profiles from the original dataset. The expression levels of 15,505 genes
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were measured with Illumina HumanHT-12 V4.0 expression beadchip. The methylation data
were measured with Illumina HumanMethylation450 BeadChip. The probes with missing val-
ues in more than 20% of the samples were removed. Thereafter, the remaining missing values
were imputed with function impute.knn (K = 10) by using R package impute (https://
bioconductor.org/packages/impute/). Lastly, 449,094 methylation probes were found. We
would like to investigate the gene expression and methylation difference between fetal intoler-
ance and control samples.
SMOTE
The dataset we analyzed here has unbalanced numbers of positive and negative samples (i.e.,
22 vs. 96). We first applied the synthetic minority oversampling technique (SMOTE) [17] to
obtain a balanced data benefitting the classification model construction. SMOTE aims to itera-
tively produce new samples for the minor sample class (i.e., fetal intolerance samples) to
ensure that the sample numbers of this minor sample class will be equivalent to that of the
major one (i.e., control samples) when SMOTE is finished. In this study, the tool “SMOTE” in
Weka is used to produce equivalent numbers of samples.
Boruta feature filtering
Boruta feature filtering [18] can filter all features relevant to the target outputs on the basis of
random forest (RF) in a wrapper manner. This algorithm recognizes important features by
comparing the importance scores corresponding to the real and shuffled features. The follow-
ing are the three main calculation steps for the Boruta approach: i) production of a new shuf-
fled dataset by copying the training dataset and shuffling the feature values; ii) calculation of
the importance score of each feature by training a RF classifier on the shuffled dataset; and iii)
evaluation of the importance score of each feature in the original training dataset to retain the
real features with remarkably higher importance scores than the shuffled features.
Feature ranking and selection
Minimum redundancy maximum relevance. Minimum redundancy maximum rele-
vance (mRMR) [19–22] holds two key assumptions: one is to select features with minimum
redundancy among themselves; and the other one is to select features with maximum rele-
vance with class labels. The mRMR filters informative features by selecting the features that
simultaneously satisfy the minimum redundancy and maximum relevance measured by
mutual information. These factors are important or informative to ensure that the following
classification model can distinguish class labels (e.g., fetal intolerance or not in this work).
Incremental feature selection. Incremental feature selection (IFS) [23] can iteratively
determine the optimal number of selected features with feature order. First, IFS selects a series
of feature subsets from the mRMR ranked features. For example, the first selected feature sub-
set consists of the top-ranked one feature, and the second one is composed of the top-ranked
two features. In each training data consisting of features from each feature subset, IFS trains
one classification model. The performance is evaluated in the 10-fold cross-validation [24].
Finally, IFS selects the feature subset with optimal performance as the optimum feature subset.
Classification algorithm. RF. RF [25–27] creates an assemble classification model con-
sisting of several tree classifiers. The RF determines the predicted sample class/category by an
aggregating vote from multiple tree classifiers (i.e., decision trees). The RF produces the final
consensus results by averaging all decision trees’ predictions because a subtle difference exists
between each decision tree. Accordingly, overfitting is avoided, and the model performance
robustness is improved.
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Support vector machine. The support vector machine (SVM) [28–31] is a classification
model based on statistical learning theory. This model can map data samples to a given data
class/category. SVM aims to transform the original data from a low-dimensional data space to
a high-dimensional one by using a given kernel function (e.g., Gaussian kernel). Thereafter,
the model can divide the data samples of each class/category by maximizing the data interval
in the high-dimensional data space during training. Subsequently, the model further predicts/
tests a new sample’ category depending on the interval where this new sample belongs. In this
study, we use the sequence minimization optimization algorithm implemented in Weka soft-
ware [32, 33] to create an SVM for a two-class classification model.
Rule learning classifier RIPPER. We used RIPPER [34] generating classification rules to
classify the samples from different classes/categories. RIPPER can predict new data by learning
the interpretable classification model in accordance with the IF–ELSE rules. Moreover, RIP-
PER can learn all rules for each sample class; it learns the rules for one class and then moves to
learn the rules for the next class. Learning starts from the minority sample class and then to
the second minority sample class until the dominant class. In this study, the “JRip” algorithm
implemented in Weka software was used.
Performance evaluation
In this study, a commonly used evaluation method, namely, the Matthew correlation coeffi-
cient [35–37] (MCC), is used to evaluate the prediction performance of each classification
model within a 10-fold cross-validation. MCC has a value ranging between −1 and +1 and
achieves +1 when the classification model has a good performance. In this study, we evaluate
the two-class classification models. Thus, the MCC for binary problem is adopted as follows:
MCC ¼
TP � TN   FP� FN
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðTP þ FPÞðTP þ FNÞðTN þ FPÞðTN þ FNÞ
p ; ð1Þ
where TP, TN, FP, and FN are the number of true-positive, true-negative, false-positive, and
false-negative samples, respectively. Furthermore, we also counted sensitivity (SN), specificity
(SP) and accuracy (ACC) for each model to give a full evaluation.
Results and discussion
In this study, we adopted several advanced computational methods to analyze the gene expres-
sion and methylation profiles of fetal intolerance. The whole procedures are illustrated in Fig
1. This section gave the detailed results and performed the discussion on the results.
Results of Boruta and mRMR
The dataset was first analyzed by Boruta to select key features. 15 relevant features were kept,
which are provided in S1 Table. These features were further evaluated by mRMR method, a
feature list was generated, which are also available in S1 Table.
Selected features and classification models for distinguishing pregnant
patients with or without fetal intolerance
Of the obtained feature list, IFS method generated several feature subsets in a way that the top
feature comprised the first feature subset, the top two features constituted the second feature
subset, and so forth. Fifteen feature subsets were accessed. For each feature subset, a classifica-
tion model was built using one of the three classification algorithms (RF, SVM and RIPPER).
Each model was evaluated by 10-fold cross-validation. This procedure employed SMOTE to
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tackle the problem that control samples were much more than fetal intolerance sample.
Obtained SNs, SP, ACCs and MCCs are listed in Tables 1–3. For an easy observation, we plot-
ted a curve for the IFS results with each classification algorithm, as shown in Fig 2, in which
MCC was set as Y-axis and the number of features was set as X-axis. For SVM, the highest
MCC was 0.796, which was obtained by the top 10 features. Thus, we can build an optimum
SVM model with these top 10 features. The other three measurements (SN, SP and ACC) of
such model are listed in Table 2. The highest MCC was 0.832 for RF when top 11 features
were adopted. Accordingly, an optimum RF model was built with these top 11 features. The
Fig 1. Whole procedures for analyzing the gene expression and methylation profiles of fetal intolerance. The
original dataset is retrieved from Gene Expression Omnibus. Some feature selection methods (Boruta feature filtering
and minimum redundancy maximum relevance) follow to analyze the dataset, resulting in a feature list. Incremental
feature selection generates several feature subsets from the feature list, on each of which a model is built using one of
three classification algorithms. Models are tested by 10-fold cross-validation using synthetic minority oversampling
technique to tackle imbalanced problem. Finally, some efficient classifiers, essential genes and decision rules are
obtained.
https://doi.org/10.1371/journal.pone.0250032.g001
Table 1. IFS performance with RF and different top features.
Number of features Sensitivity Specificity Accuracy Matthew correlation coefficient
1 0.677 0.727 0.686 0.322
2 0.813 0.909 0.831 0.601
3 0.854 0.727 0.831 0.520
4 0.906 0.818 0.890 0.672
5 0.906 0.909 0.907 0.738
6 0.917 0.864 0.907 0.723
7 0.927 0.909 0.924 0.775
8 0.917 0.909 0.915 0.756
9 0.938 0.909 0.932 0.796
10 0.958 0.818 0.932 0.777
11 0.969 0.864 0.949 0.832
12 0.938 0.864 0.924 0.764
13 0.938 0.864 0.924 0.764
14 0.938 0.864 0.924 0.764
15 0.948 0.909 0.941 0.817
https://doi.org/10.1371/journal.pone.0250032.t001
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SN, SP and ACC of this model are provided in Table 1. Evidently, the optimum RF model was
superior to the optimum SVM model.
As RF and SVM are black-box algorithms, their classification principle is hard to under-
stand. Thus, few insights can be obtained. In view of this, we further applied RIPPER in a simi-
lar way. The IFS performance is shown in Table 3, from which a curve was plotted, as
illustrated in Fig 2. The best MCC was 0.687 when top 13 features were used. Thus, an opti-
mum RIPPER model was set up with these features. Other three measurements of this model
are listed in Table 3. Clearly, such model was inferior to the optimum RF and SVM models.
However, some rules can be extracted from this model, which clearly displayed the classifica-
tion procedures. Based on top 13 features, we obtained five rules via RIPPER, which are listed
in Table 4.
Table 2. IFS performance with SVM and different top features.
Number of features Sensitivity Specificity Accuracy Matthew correlation coefficient
1 0.938 0.591 0.873 0.560
2 0.875 0.818 0.864 0.620
3 0.885 0.773 0.864 0.603
4 0.885 0.773 0.864 0.603
5 0.885 0.818 0.873 0.636
6 0.865 0.864 0.864 0.638
7 0.917 0.864 0.907 0.723
8 0.927 0.864 0.915 0.743
9 0.927 0.909 0.924 0.775
10 0.938 0.909 0.932 0.796
11 0.948 0.864 0.932 0.785
12 0.927 0.864 0.915 0.743
13 0.927 0.864 0.915 0.743
14 0.927 0.864 0.915 0.743
15 0.927 0.864 0.915 0.743
https://doi.org/10.1371/journal.pone.0250032.t002
Table 3. IFS performance with RIPPER and different top features.
Number of features Sensitivity Specificity Accuracy Matthew correlation coefficient
1 0.802 0.636 0.771 0.380
2 0.750 0.773 0.754 0.428
3 0.823 0.773 0.814 0.512
4 0.833 0.773 0.822 0.526
5 0.760 0.682 0.746 0.369
6 0.865 0.909 0.873 0.671
7 0.854 0.864 0.856 0.623
8 0.865 0.818 0.856 0.604
9 0.875 0.864 0.873 0.654
10 0.875 0.818 0.864 0.620
11 0.875 0.818 0.864 0.620
12 0.896 0.727 0.864 0.586
13 0.896 0.864 0.890 0.687
14 0.875 0.818 0.864 0.620
15 0.885 0.864 0.881 0.670
https://doi.org/10.1371/journal.pone.0250032.t003
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As previously mentioned, we presented various qualitative and quantitative novel computa-
tional approaches to distinguish pregnant patients with fetal intolerance from healthy pregnant
women dependent on their personal blood gene expression and methylation profiles. We not
only identified a group of effective genes with a specific gene expression or methylation pattern
that contributes to the diagnosis of fetal intolerance but also attempted to set up a set of quanti-
tative rules for accurate and interpretable prediction on the basis of our methods. All the pre-
dicted gene expression and methylation patterns and their quantitative rules have been
confirmed by recent publications. The detailed analysis and discussion on the top-ranked
genes and rules can be seen below.
Optimal genes for fetal intolerance diagnosis and monitoring
Our newly presented computational methods identified fifteen methylation sites that are cor-
related with fetal intolerance and involved in five genes: NHEDC1, COMTD1, DLGAP2,
HEG1, and KIAA1875.
The first gene (NHEDC1) with five methylation sites, also known as SLC9B1, has been
widely reported to participate in the intracellular pH regulation in germ cells [38]. Such gene
has been reported to have quite various biological effects with different methylation statuses
[39, 40]. The abnormal methylation of such gene has been confirmed to participate in cell dif-
ferentiation [39]. Such gene has already been reported as a typical biomarker for the clinical
prediction of fetal intolerance [16], thereby validating the efficacy and accuracy of our
prediction.
The second gene is COMTD1, which encodes an effective methyltransferase with O-methyl-
transferase activity [41–43]. No direct evidence confirmed that COMTD1 can independently
predict fetal intolerance; however, COMTD1 in a mother’s blood is correlated with several
congenital disorders, such as psychotic diseases and autism [44]. Given that congenital
Table 4. Decision rules generated by RIPPER on selected features.
Index Condition Result
Rule1 (cg23159165< = 0.4524) and (cg26222765< = 0.8847) Fetal intolerance sample
Rule2 (cg04944931 < = 0.8437) and (cg00510160< = 0.7120) Fetal intolerance sample
Rule3 (cg19672271 > = 0.05775) and (cg00510160 < = 0.7221) Fetal intolerance sample
Rule4 (cg04944931 < = 0.6588) Fetal intolerance sample
Rule5 Others Control sample
https://doi.org/10.1371/journal.pone.0250032.t004
Fig 2. IFS curves based on the ordered features from RF, SVM, and RIPPER. The model with RF and top 11
features is the best, which produces the MCC of 0.832.
https://doi.org/10.1371/journal.pone.0250032.g002
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disorders are among the major inducements for fetal intolerance [45, 46], biomarkers are cor-
related with such gene to monitor this condition. Furthermore, COMTD1 has been confirmed
to be detectable in the blood on the methylation level [43]. This finding confirms the potentials
of such gene as an effective biomarker for fetal intolerance prediction and monitoring.
DLGAP2 is the third gene encoding a specific membrane associated protein and has been
widely reported to participate in the molecular organization of synapses and neuronal cell sig-
naling [47, 48]. In 2019, an independent study confirmed that the methylation status of such
gene in the blood can monitor the blood sugar level of mothers and maternal insulin sensitivity
during pregnancy [49, 50]. Considering that the blood sugar level of mothers is also patholog-
ically correlated with fetal intolerance [51, 52], such gene can be regarded as a potential bio-
marker during fetal intolerance monitoring and diagnosis.
HEG1 is a quite effective regulator for the heart and vessels during the early developmental
stage [53]. In 2019, a report confirmed that the abnormal methylation regulation on such gene
may induce trophoblast invasion at the maternal–fetal interface, thereby inducing a high level
of mothers’ psychological distress [54] and the abnormal development of fetal hearts [54, 55],
even though not validated in human beings. Considering that fetal heart development has also
been predicted to be correlated with fetal intolerance [56–58], HEG1 can be regarded as an
effective biomarker for fetal intolerance prediction. Gene KIAA1875 known as WDR97 has
been reported as a blood biomarker with moderate functional annotations [59]. This gene has
also been confirmed to be detectable at the epigenomic level in the blood [60]. Thus,
KIAA1875 may act as a quality control biomarker to measure the reliability of the samples,
although no direct reports at present has confirmed its specific role in fetal intolerance
prediction.
Optimal rules for fetal intolerance diagnosis and monitoring
We set up a group of quantitative rules for diagnosing the fetal intolerance in clinical applica-
tion in addition to above qualitative analysis. The four rules are used to evaluate the risk of
pregnant mothers suffering from fetal intolerance. Five methylation sites with specific methyl-
ation tendency (hypermethylation or hypomethylation) contribute to the prediction of these
rules. Among these methylation sites, two genes are annotated: COMTD1 and NHEDC1.
These genes have already been confirmed to be functionally correlated with fetal intolerance in
the above analysis.
The hypermethylation of NHEDC1 and the hypomethylation of COMTD1 contribute to the
identification of patients with fetal intolerance, thereby revealing the specific methylation ten-
dency (hypermethylation or hypomethylation) from the rules. Recent studies have shown that
the methylation of NHEDC1 can indicate the onset of fetal intolerance [16], thereby support-
ing this prediction. COMTD1 is functionally correlated with fetal intolerance, and its hypo-
methylation may cause abnormal congenital disorders [41], thereby inducing pathological
fetal intolerance. Therefore, these quantitative rules contribute to the accurate prediction of
fetal intolerance using blood samples.
Conclusion
In summary, the optimal genes and rules we identified in this study have all been supported by
recent publications. The efficacy and accuracy of our prediction have also been validated. The
blood gene methylation profiling of certain effective biomarkers may be accurate and effective
enough for the clinical monitoring of fetal intolerance during pregnancy by using our newly
presented computational approaches. Therefore, this work may not only reveal several
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potential pathological factors for fetal intolerance but also set up a set of potential diagnostic
standards (biomarkers and rules) for the clinical monitoring and diagnosis of fetal intolerance.
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Supervision: José Escorcia-Gutierrez, Tao Huang, Yu-Dong Cai.
Writing – original draft: Yu-Hang Zhang, Zhandong Li.
Writing – review & editing: Tao Huang, Yu-Dong Cai.
References
1. Bondas T, Eriksson K (2001) Women’s lived experiences of pregnancy: A tapestry of joy and suffering.
Qualitative Health Research 11: 824–840. https://doi.org/10.1177/104973201129119415 PMID:
11710080
2. Macklin R (2010) Enrolling pregnant women in biomedical research. The Lancet 375: 632–633. https://
doi.org/10.1016/s0140-6736(10)60257-7 PMID: 20198725
3. Yap S-C, Drenthen W, Pieper PG, Moons P, Mulder BJ, et al. (2008) Risk of complications during preg-
nancy in women with congenital aortic stenosis. International journal of cardiology 126: 240–246.
https://doi.org/10.1016/j.ijcard.2007.03.134 PMID: 17482293
4. Linne Y (2004) Effects of obesity on women’s reproduction and complications during pregnancy. Obe-
sity reviews 5: 137–143. https://doi.org/10.1111/j.1467-789X.2004.00147.x PMID: 15245382
5. Dietl J (2005) Maternal obesity and complications during pregnancy. Journal of perinatal medicine 33:
100–105. https://doi.org/10.1515/JPM.2005.018 PMID: 15843256
6. Wood SL, Newton JM, Wang L, Lesser K (2014) Borderline Amniotic Fluid Index and Its Relation to
Fetal Intolerance of Labor: A 2-Center Retrospective Cohort Study. Journal of Ultrasound in Medicine
33: 705–711. https://doi.org/10.7863/ultra.33.4.705 PMID: 24658952
7. Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie J, et al. (1995) Impact of increasing carbohydrate
intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-
Hospital Gestational Diabetes Project. American journal of obstetrics and gynecology 173: 146–156.
https://doi.org/10.1016/0002-9378(95)90183-3 PMID: 7631672
8. Sacks D (1993) Fetal macrosomia and gestational diabetes: what’s the problem? Obstetrics and gyne-
cology 81: 775–781. PMID: 8469471
9. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, et al. (1985) Antibody to cardiolipin as a predic-
tor of fetal distress or death in pregnant patients with systemic lupus erythematosus. New England Jour-
nal of Medicine 313: 152–156. https://doi.org/10.1056/NEJM198507183130304 PMID: 3925336
10. Impey L (1993) Severe hypotension and fetal distress following sublingual administration of nifedipine
to a patient with severe pregnancy induced hypertension at 33 weeks. BJOG: An International Journal
of Obstetrics & Gynaecology 100: 959–961. https://doi.org/10.1111/j.1471-0528.1993.tb15120.x
PMID: 8217985
11. Laurin J, Lingman G, Marsál K, Persson P (1987) Fetal blood flow in pregnancies complicated by intra-
uterine growth retardation. Obstetrics and Gynecology 69: 895–902. PMID: 3554065
12. Heitzer E, Haque IS, Roberts CE, Speicher MR (2019) Current and future perspectives of liquid biopsies
in genomics-driven oncology. Nature Reviews Genetics 20: 71–88. https://doi.org/10.1038/s41576-
018-0071-5 PMID: 30410101
13. San Lucas F, Allenson K, Bernard V, Castillo J, Kim D, et al. (2016) Minimally invasive genomic and
transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
Annals of Oncology 27: 635–641. https://doi.org/10.1093/annonc/mdv604 PMID: 26681674
PLOS ONE Methylation signatures for fetal intolerance
PLOS ONE | https://doi.org/10.1371/journal.pone.0250032 April 22, 2021 9 / 12
14. Kim Y, Jeon J, Mejia S, Yao CQ, Ignatchenko V, et al. (2016) Targeted proteomics identifies liquid-
biopsy signatures for extracapsular prostate cancer. Nature communications 7: 1–10. https://doi.org/
10.1038/ncomms11906 PMID: 27350604
15. Ying W, Jingli F, Wei SW, Li WL (2010) Genomic imprinting status of IGF-II and H19 in placentas of
fetal growth restriction patients. J Genet 89: 213–216. https://doi.org/10.1007/s12041-010-0027-9
PMID: 20861572
16. Knight AK, Conneely KN, Kilaru V, Cobb D, Payne JL, et al. (2018) SLC9B1 methylation predicts fetal
intolerance of labor. Epigenetics 13: 33–39. https://doi.org/10.1080/15592294.2017.1411444 PMID:
29235940
17. Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP (2002) SMOTE: Synthetic minority over-sampling
technique. Journal of Artificial Intelligence Research 16: 321–357.
18. Kursa M, Rudnicki W (2010) Feature Selection with the Boruta Package. Journal of Statistical Software,
Articles 36: 1–13.
19. Peng HC, Long FH, Ding C (2005) Feature selection based on mutual information: Criteria of max-
dependency, max-relevance, and min-redundancy. Ieee Transactions on Pattern Analysis And
Machine Intelligence 27: 1226–1238. https://doi.org/10.1109/TPAMI.2005.159 PMID: 16119262
20. Pan X, Li H, Zeng T, Li Z, Chen L, et al. (2021) Identification of protein subcellular localization with net-
work and functional embeddings. Frontiers in Genetics 11: 626500. https://doi.org/10.3389/fgene.
2020.626500 PMID: 33584818
21. Zhang Y-H, Li H, Zeng T, Chen L, Li Z, et al. (2021) Identifying transcriptomic signatures and rules for
SARS-CoV-2 infection. Frontiers in Cell and Developmental Biology 8: 627302. https://doi.org/10.3389/
fcell.2020.627302 PMID: 33505977
22. Zhao X, Chen L, Lu J (2018) A similarity-based method for prediction of drug side effects with heteroge-
neous information. Mathematical Biosciences 306: 136–144. https://doi.org/10.1016/j.mbs.2018.09.
010 PMID: 30296417
23. Liu HA, Setiono R (1998) Incremental feature selection. Applied Intelligence 9: 217–230.
24. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection; 1995.
Lawrence Erlbaum Associates Ltd. pp. 1137–1145.
25. Breiman L (2001) Random forests. Machine learning 45: 5–32.
26. Jia Y, Zhao R, Chen L (2020) Similarity-Based Machine Learning Model for Predicting the Metabolic
Pathways of Compounds. IEEE Access 8: 130687–130696.
27. Liang H, Chen L, Zhao X, Zhang X (2020) Prediction of drug side effects with a refined negative sample
selection strategy. Computational and Mathematical Methods in Medicine 2020: 1573543. https://doi.
org/10.1155/2020/1573543 PMID: 32454877
28. Cortes C, Vapnik V (1995) Support-vector networks. Machine Learning 20: 273–297.
29. Zhou J-P, Chen L, Guo Z-H (2020) iATC-NRAKEL: An efficient multi-label classifier for recognizing ana-
tomical therapeutic chemical classes of drugs. Bioinformatics 36: 1391–1396. https://doi.org/10.1093/
bioinformatics/btz757 PMID: 31593226
30. Zhou J-P, Chen L, Wang T, Liu M (2020) iATC-FRAKEL: A simple multi-label web-server for recogniz-
ing anatomical therapeutic chemical classes of drugs with their fingerprints only. Bioinformatics 36:
3568–3569. https://doi.org/10.1093/bioinformatics/btaa166 PMID: 32154836
31. Zhu Y, Hu B, Chen L, Dai Q (2021) iMPTCE-Hnetwork: a multi-label classifier for identifying metabolic
pathway types of chemicals and enzymes with a heterogeneous network. Computational and Mathe-
matical Methods in Medicine 2021: 6683051. https://doi.org/10.1155/2021/6683051 PMID: 33488764
32. Frank E, Hall M, Trigg L, Holmes G, Witten IH (2004) Data mining in bioinformatics using Weka. Bioin-
formatics 20: 2479–2481. https://doi.org/10.1093/bioinformatics/bth261 PMID: 15073010
33. Witten IH, Frank E (2005) Data Mining: Practical machine learning tools and techniques: Morgan Kauf-
mann Pub.
34. Cohen WW (1995) Fast Effective Rule Induction. Twelfth International Conference on Machine
Learning. pp. 115–123.
35. Matthews B (1975) Comparison of the predicted and observed secondary structure of T4 phage lyso-
zyme. Biochimica et Biophysica Acta (BBA)-Protein Structure 405: 442–451. https://doi.org/10.1016/
0005-2795(75)90109-9 PMID: 1180967
36. Zhang Y-H, Zeng T, Chen L, Huang T, Cai Y-D (2021) Detecting the multiomics signatures of factor-
specific inflammatory effects on airway smooth muscles. Frontiers in Genetics 11: 599970. https://doi.
org/10.3389/fgene.2020.599970 PMID: 33519902
37. Liu H, Hu B, Chen L, Lu L (2020) Identifying protein subcellular location with embedding features
learned from networks. Current Proteomics.
PLOS ONE Methylation signatures for fetal intolerance
PLOS ONE | https://doi.org/10.1371/journal.pone.0250032 April 22, 2021 10 / 12
38. Kumar PL, James PF (2015) Identification and characterization of methylation-dependent/independent
DNA regulatory elements in the human SLC9B1 gene. Gene 561: 235–248. https://doi.org/10.1016/j.
gene.2015.02.050 PMID: 25701605
39. Hargan Calvopina JD (2016) Mechanisms of demethylation in primordial germ cells and the importance
of stage-specific demethylation in safeguarding against precocious differentiation: UCLA. https://doi.
org/10.1016/j.devcel.2016.07.019 PMID: 27618282
40. Auclair G, Borgel J, Sanz LA, Vallet J, Guibert S, et al. (2016) EHMT2 directs DNA methylation for effi-
cient gene silencing in mouse embryos. Genome research 26: 192–202. https://doi.org/10.1101/gr.
198291.115 PMID: 26576615
41. Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, et al. (2013) Comprehensive DNA methylation
analysis of peripheral blood cells derived from patients with first-episode schizophrenia. Journal of
human genetics 58: 91–97. https://doi.org/10.1038/jhg.2012.140 PMID: 23235336
42. Wockner LF, Noble EP, Lawford BR, Young RM, Morris CP, et al. (2014) Genome-wide DNA methyla-
tion analysis of human brain tissue from schizophrenia patients. Translational psychiatry 4: e339–
e339. https://doi.org/10.1038/tp.2013.111 PMID: 24399042
43. Houseman EA, Kim S, Kelsey KT, Wiencke JK (2015) DNA methylation in whole blood: uses and chal-
lenges. Current environmental health reports 2: 145–154. https://doi.org/10.1007/s40572-015-0050-3
PMID: 26231364
44. Abdolmaleky HM, Zhou J-R, Thiagalingam S (2015) An update on the epigenetics of psychotic diseases
and autism. Epigenomics 7: 427–449. https://doi.org/10.2217/epi.14.85 PMID: 26077430
45. Zaki M, Boyd P, Impey L, Roberts A, Chamberlain P (2007) Congenital myotonic dystrophy: prenatal
ultrasound findings and pregnancy outcome. Ultrasound in Obstetrics and Gynecology: The Official
Journal of the International Society of Ultrasound in Obstetrics and Gynecology 29: 284–288. https://
doi.org/10.1002/uog.3859 PMID: 17238150
46. Panigrahy N, Lingappa L, Ramadevi AR, Venkatlakshmi A (2016) Congenital disorder of glycosylation
(CDG) presenting as non-immune hydrops fetalis. The Indian Journal of Pediatrics 83: 359–360.
https://doi.org/10.1007/s12098-015-1895-z PMID: 26365158
47. Poquet H, Faivre L, El Chehadeh S, Morton J, McMullan D, et al. (2017) Further Evidence for Dlgap2 as
strong Autism Spectrum disorders/intellectual disability candidate gene. Autism Open Access 6: 2.
48. Chertkow-Deutsher Y, Cohen H, Klein E, Ben-Shachar D (2010) DNA methylation in vulnerability to
post-traumatic stress in rats: evidence for the role of the post-synaptic density protein Dlgap2. Interna-
tional Journal of Neuropsychopharmacology 13: 347–359. https://doi.org/10.1017/
S146114570999071X PMID: 19793403
49. Hivert M-F, Cardenas A, Allard C, Doyon M, Powe CE, et al. (2020) Interplay of Placental DNA Methyla-
tion and Maternal Insulin Sensitivity in Pregnancy. Diabetes 69: 484–492. https://doi.org/10.2337/
db19-0798 PMID: 31882564
50. De Felice B, Manfellotto F, Palumbo A, Troisi J, Zullo F, et al. (2015) Genome–wide microRNA expres-
sion profiling in placentas from pregnant women exposed to BPA. BMC medical genomics 8: 56.
https://doi.org/10.1186/s12920-015-0131-z PMID: 26345457
51. Luo ZC, Nuyt AM, Delvin E, Fraser WD, Julien P, et al. (2013) Maternal and fetal leptin, adiponectin lev-
els and associations with fetal insulin sensitivity. Obesity 21: 210–216. https://doi.org/10.1002/oby.
20250 PMID: 23505188
52. El Mallah K, Narchi H, Kulaylat N, Shaban M (1997) Gestational and pre-gestational diabetes: compari-
son of maternal and fetal characteristics and outcome. International Journal of Gynecology & Obstetrics
58: 203–209. https://doi.org/10.1016/s0020-7292(97)00084-2 PMID: 9252256
53. Donat S, Lourenço M, Paolini A, Otten C, Renz M, et al. (2018) Heg1 and Ccm1/2 proteins control endo-
cardial mechanosensitivity during zebrafish valvulogenesis. Elife 7: e28939. https://doi.org/10.7554/
eLife.28939 PMID: 29364115
54. Ramos CJ, Antonetti DA (2017) The role of small GTPases and EPAC-Rap signaling in the regulation
of the blood-brain and blood-retinal barriers. Tissue barriers 5: e1339768. https://doi.org/10.1080/
21688370.2017.1339768 PMID: 28632993
55. Groenendijk BC, Hierck BP, Gittenberger-de Groot AC, Poelmann RE (2004) Development-related
changes in the expression of shear stress responsive genes KLF-2, ET-1, and NOS-3 in the developing
cardiovascular system of chicken embryos. Developmental dynamics: an official publication of the
American Association of Anatomists 230: 57–68.
56. Sarnat HB, Sarnat MS (1976) Neonatal encephalopathy following fetal distress: a clinical and electroen-
cephalographic study. Archives of neurology 33: 696–705. https://doi.org/10.1001/archneur.1976.
00500100030012 PMID: 987769
PLOS ONE Methylation signatures for fetal intolerance
PLOS ONE | https://doi.org/10.1371/journal.pone.0250032 April 22, 2021 11 / 12
57. Chung D, Sim Y, Park K, Yi S, Shin J, et al. (2001) Spectral analysis of fetal heart rate variability as a
predictor of intrapartum fetal distress. International Journal of Gynecology & Obstetrics 73: 109–116.
58. Zuspan FP, Quilligan E, Iams JD, van Geijn HP (1979) Predictors of intrapartum fetal distress: The role
of electronic fetal monitoring: Report of the National Institute of Child Health and Human Development
Consensus Development Task Force. American Journal of Obstetrics & Gynecology 135: 287–291.
59. Vieira SE, Bando SY, de Paulis M, Oliveira DB, Thomazelli LM, et al. (2019) Distinct transcriptional
modules in the peripheral blood mononuclear cells response to human respiratory syncytial virus or to
human rhinovirus in hospitalized infants with bronchiolitis. PloS one 14: e0213501. https://doi.org/10.
1371/journal.pone.0213501 PMID: 30845274
60. Lim JH, Kang Y-J, Lee BY, Han YJ, Chung JH, et al. (2019) Epigenome-wide base-resolution profiling
of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing. Clin-
ical Epigenetics 11: 180. https://doi.org/10.1186/s13148-019-0756-4 PMID: 31801612
PLOS ONE Methylation signatures for fetal intolerance
PLOS ONE | https://doi.org/10.1371/journal.pone.0250032 April 22, 2021 12 / 12
